Your browser doesn't support javascript.
loading
Validation of the Hospital Episode Statistics Outpatient Dataset in England.
Thorn, Joanna C; Turner, Emma; Hounsome, Luke; Walsh, Eleanor; Donovan, Jenny L; Verne, Julia; Neal, David E; Hamdy, Freddie C; Martin, Richard M; Noble, Sian M.
Afiliación
  • Thorn JC; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. joanna.thorn@bristol.ac.uk.
  • Turner E; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
  • Hounsome L; Public Health England Knowledge and Intelligence Team (South West), 2 Rivergate, Temple Quay, Bristol, BS1 6EH, UK.
  • Walsh E; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
  • Donovan JL; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
  • Verne J; Public Health England Knowledge and Intelligence Team (South West), 2 Rivergate, Temple Quay, Bristol, BS1 6EH, UK.
  • Neal DE; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Box 279 (S4), Hills Road, Cambridge, CB2 0QQ, UK.
  • Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ, UK.
  • Martin RM; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
  • Noble SM; School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
Pharmacoeconomics ; 34(2): 161-8, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26386702
OBJECTIVES: The Hospital Episode Statistics (HES) dataset is a source of administrative 'big data' with potential for costing purposes in economic evaluations alongside clinical trials. This study assesses the validity of coverage in the HES outpatient dataset. METHODS: Men who died of, or with, prostate cancer were selected from a prostate-cancer screening trial (CAP, Cluster randomised triAl of PSA testing for Prostate cancer). Details of visits that took place after 1/4/2003 to hospital outpatient departments for conditions related to prostate cancer were extracted from medical records (MR); these appointments were sought in the HES outpatient dataset based on date. The matching procedure was repeated for periods before and after 1/4/2008, when the HES outpatient dataset was accredited as a national statistic. RESULTS: 4922 outpatient appointments were extracted from MR for 370 men. 4088 appointments recorded in MR were identified in the HES outpatient dataset (83.1%; 95% confidence interval [CI] 82.0-84.1). For appointments occurring prior to 1/4/2008, 2195/2755 (79.7%; 95% CI 78.2-81.2) matches were observed, while 1893/2167 (87.4%; 95% CI 86.0-88.9) appointments occurring after 1/4/2008 were identified (p for difference <0.001). 215/370 men (58.1%) had at least one appointment in the MR review that was unmatched in HES, 155 men (41.9%) had all their appointments identified, and 20 men (5.4%) had no appointments identified in HES. CONCLUSIONS: The HES outpatient dataset appears reasonably valid for research, particularly following accreditation. The dataset may be a suitable alternative to collecting MR data from hospital notes within a trial, although caution should be exercised with data collected prior to accreditation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proyectos de Investigación / Bases de Datos Factuales / Economía Médica Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proyectos de Investigación / Bases de Datos Factuales / Economía Médica Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Límite: Aged / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Pharmacoeconomics Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2016 Tipo del documento: Article